Sedigheh Saedi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sedigheh Saedi has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
- Zahra Khajali
Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Institute, Iran University of Medical Sciences, Tehran (A.F., Z.K.).
6 shared publications Ata Firouzi
Cardiovascular Intervention Research Center Rajaie Cardiovascular Institute Tehran Iran
5 shared publicationsHamid Reza Pouraliakbar
Rajaie Cardiovascular Institute Tehran Iran
5 shared publicationsMozhgan Parsaee
Echocardiography Research Center, Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
5 shared publicationsTahereh Saedi
Iran University of Medical Sciences, Tehran, Iran
5 shared publications- Majid Maleki
Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
4 shared publications
Latest Publications
- 5 May 2025
- Published by Wiley in Echocardiography
- Vol. 42 (5) , e70181
Reverse Cardiac Remodeling Induced by Endovascular Treatment of Coarctation of the Aorta
Background: Limited research has explored the transformation of echocardiographic parameters during mid‐ to long‐term follow‐up in patients with native coarctation of the aorta (CoA) managed through stenting. This study assesses changes in echocardiographic parameters among patients undergoing stent coarctoplasty, by comparing baseline and 3‐year transthoracic echocardiographic (TTE) parameters.Methods: In our earlier work, we detailed the 3‐year clinical safety and efficacy outcomes of balloon‐expandable versus self‐expandable stents for treating native CoA within a randomized clinical trial. The current substudy aims to assess the mid‐term effects of stenting by examining all participants with available baseline and 3‐year core laboratory‐confirmed TTE data.Results: Of the 92 patients enrolled in the randomized trial, 32 individuals (median age: 32 years [IQR: 24.8–37.5]) were included in this substudy. At the 3‐year follow‐up, significant improvements were observed in myocardial diastolic function, characterized by increased septal E′ and lateral E′ velocities (p = 0.02 and p = 0.03, respectively) and decreased septal and lateral E/E′ ratios (10.84 ± 2.83 to 9.21 ± 3.17, p = 0.02 and 7.39 ± 2.24 to 6.29 ± 1.97, p = 0.02, respectively). At the 3‐year follow‐up, a significant reduction in left ventricular (LV) mass was observed, decreasing from 160 g (IQR: 130–203) to 142 g (IQR: 121–172) (p = 0.001). Among the 12 patients (37.5%) presenting with baseline LV hypertrophy, nine individuals (75%) experienced normalization, demonstrating a substantial improvement in LV mass. Additionally, the prevalence of diastolic dysfunction significantly decreased from 12 patients (41.3%) to four patients (13.7%) at the 3‐year evaluation.Conclusions: In adult patients with de novo native CoA, stent coarctoplasty was found to result in significant and sustained improvements in LV diastolic function and reduced LV mass during the mid‐term follow‐up. Our findings imply that baseline structural parameters may serve as stronger predictors of long‐term therapeutic outcomes than demographic factors.Trail Registration: Iranian Registry of Clinical Trials: IRCT20181022041406N3.
- 5 May 2025
- Published by Wiley in Echocardiography
- Vol. 42 (5) , e70181
Reverse Cardiac Remodeling Induced by Endovascular Treatment of Coarctation of the Aorta
Background: Limited research has explored the transformation of echocardiographic parameters during mid‐ to long‐term follow‐up in patients with native coarctation of the aorta (CoA) managed through stenting. This study assesses changes in echocardiographic parameters among patients undergoing stent coarctoplasty, by comparing baseline and 3‐year transthoracic echocardiographic (TTE) parameters.Methods: In our earlier work, we detailed the 3‐year clinical safety and efficacy outcomes of balloon‐expandable versus self‐expandable stents for treating native CoA within a randomized clinical trial. The current substudy aims to assess the mid‐term effects of stenting by examining all participants with available baseline and 3‐year core laboratory‐confirmed TTE data.Results: Of the 92 patients enrolled in the randomized trial, 32 individuals (median age: 32 years [IQR: 24.8–37.5]) were included in this substudy. At the 3‐year follow‐up, significant improvements were observed in myocardial diastolic function, characterized by increased septal E′ and lateral E′ velocities (p = 0.02 and p = 0.03, respectively) and decreased septal and lateral E/E′ ratios (10.84 ± 2.83 to 9.21 ± 3.17, p = 0.02 and 7.39 ± 2.24 to 6.29 ± 1.97, p = 0.02, respectively). At the 3‐year follow‐up, a significant reduction in left ventricular (LV) mass was observed, decreasing from 160 g (IQR: 130–203) to 142 g (IQR: 121–172) (p = 0.001). Among the 12 patients (37.5%) presenting with baseline LV hypertrophy, nine individuals (75%) experienced normalization, demonstrating a substantial improvement in LV mass. Additionally, the prevalence of diastolic dysfunction significantly decreased from 12 patients (41.3%) to four patients (13.7%) at the 3‐year evaluation.Conclusions: In adult patients with de novo native CoA, stent coarctoplasty was found to result in significant and sustained improvements in LV diastolic function and reduced LV mass during the mid‐term follow‐up. Our findings imply that baseline structural parameters may serve as stronger predictors of long‐term therapeutic outcomes than demographic factors.Trail Registration: Iranian Registry of Clinical Trials: IRCT20181022041406N3.
- 27 February 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (5) , 1128-1130
Aortic dilation in adults with repaired tetralogy of Fallot: a single-centre study
Background: Tetralogy of Fallot is the most prevalent cyanotic CHD. With the advent of advanced surgical methods, the majority of tetralogy of Fallot patients reach adulthood. However, many need re-intervention for the residual anomalies including residual right ventricular outflow obstruction, pulmonary regurgitation, residual ventricular septal defects, and progressive aortic dilatation. Aortic dilation could lead to aortic regurgitation or dissection requiring surgical correction. In the current study, we aimed to determine the prevalence and outcomes of aortic root dilatation in adults with repaired tetralogy of Fallot in our tertiary care centre.Methods: In this retrospective study, 730 consecutive patients with history of repaired tetralogy of Fallot were included. Aortic diameter at the level of annulus, the sinus of Valsalva, sinotubular junction, and the ascending aorta as measured by echocardiography were evaluated. Prevalence of outcomes necessitating re-intervention including aortic regurgitation and dissection were recorded.Results: The mean size of annulus, sinus of Valsalva, sinotubular-junction, and ascending aorta in the latest available echocardiography of patients were 2.4+/-0.4 cm, 3.3+/-0.5 cm, 2.9+/-0.5cm, and 3.2+/-0.5cm, respectively. Prevalence of dilatation of sinus of Valsalva, dilation of Ascending aorta, sinotubular-junction, and aortic annulus was 28.7%, 21%, 8.3%, and 1 %, respectively. Five patients had severe aortic regurgitation (0.6%) and underwent surgical repair. One of these patients presented with acute aortic dissection.Conclusion: Aortic dilation is common in tetralogy of Fallot but prevalence of redo surgery for aortic dilation, regurgitation, and adverse events including acute dissection is low.
- 27 February 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (5) , 1128-1130
Aortic dilation in adults with repaired tetralogy of Fallot: a single-centre study
Background: Tetralogy of Fallot is the most prevalent cyanotic CHD. With the advent of advanced surgical methods, the majority of tetralogy of Fallot patients reach adulthood. However, many need re-intervention for the residual anomalies including residual right ventricular outflow obstruction, pulmonary regurgitation, residual ventricular septal defects, and progressive aortic dilatation. Aortic dilation could lead to aortic regurgitation or dissection requiring surgical correction. In the current study, we aimed to determine the prevalence and outcomes of aortic root dilatation in adults with repaired tetralogy of Fallot in our tertiary care centre.Methods: In this retrospective study, 730 consecutive patients with history of repaired tetralogy of Fallot were included. Aortic diameter at the level of annulus, the sinus of Valsalva, sinotubular junction, and the ascending aorta as measured by echocardiography were evaluated. Prevalence of outcomes necessitating re-intervention including aortic regurgitation and dissection were recorded.Results: The mean size of annulus, sinus of Valsalva, sinotubular-junction, and ascending aorta in the latest available echocardiography of patients were 2.4+/-0.4 cm, 3.3+/-0.5 cm, 2.9+/-0.5cm, and 3.2+/-0.5cm, respectively. Prevalence of dilatation of sinus of Valsalva, dilation of Ascending aorta, sinotubular-junction, and aortic annulus was 28.7%, 21%, 8.3%, and 1 %, respectively. Five patients had severe aortic regurgitation (0.6%) and underwent surgical repair. One of these patients presented with acute aortic dissection.Conclusion: Aortic dilation is common in tetralogy of Fallot but prevalence of redo surgery for aortic dilation, regurgitation, and adverse events including acute dissection is low.
- Open Access
- 21 November 2023
- Published by Knowledge E DMCC in The Journal of Tehran University Heart Center
- Vol. 18 (3) , 234-236
First Experiences With Vascular Closure Devices in the Endovascular Treatment of Aortic Coarctation
The Article Abstract is not available.
- 21 November 2023
- Published by Knowledge E DMCC in The Journal of Tehran University Heart Center
- Vol. 18 (3) , 234-236
Open AccessFirst Experiences With Vascular Closure Devices in the Endovascular Treatment of Aortic Coarctation
The Article Abstract is not available.
- Open Access
- 10 July 2023
- Published by Brieflands in International Journal of Cardiovascular Practice
- Vol. 7 (2)
Surgical Outcomes of Repairing Ebstein Anomaly: A Single-Center Experience
Background: Ebstein anomaly (EA) is a rare congenital disorder of the tricuspid valve (TV), accounting for about one percent of congenital heart defects. Considering highly variable anatomy, diverse corrective surgical methods are currently utilized. Cone reconstruction provides a near anatomic tricuspid restoration method that has triggered enthusiasm for early repair over recent years. Objectives: In the current study, we aimed to evaluate the clinical and echocardiographic features and outcomes of patients who underwent surgical correction of EA in our referral center. Methods: In this study, we reviewed the medical records of 35 patients with EA who underwent cone repair or TV replacement and had accessible echocardiographic data before and at least one year following the corrective surgery. The patients were evaluated for residual tricuspid regurgitation (TR) severity, right ventricular (RV) size, RV fractional area change (FAC), left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), and 2D left ventricular ejection fraction (LVEF) before and after the operation. Results: Mean age of the patients was 29.49 ± 9.13 years, and 54.3% of them were female. Twenty-one (60%) patients underwent cone repair, and 14 were subjected to TV replacement. Seven (20%) patients required reoperation; redo TV repair was conducted in three patients (8.6%); two (5.7%) patients underwent biologic TV replacement; mechanical TV replacement was performed in one patient (2.9%) who had degenerative biologic TVs, and one patient (2.9%) was subjected to redo-operation due to mechanical TV malfunction. Positive changes in the means of RV-FAC and 2D-LVEF were statistically significant in all patients irrespective of the type of surgery (P < 0.001), but changes in the means of RV size (P = 0.38) and LVESD (P = 0.302) were not statistically significant. There was a significant increase in functional RV size in both groups of patients who underwent repair (P = 0.063) or replacement (P = 0.02). Conclusions: The present study revealed satisfactory post-op results for cone TV repair in patients with EA, evidenced by reduced TR severity and improved biventricular functional parameters. Assessing the durability of the outcomes of cone TV repair needs longer-term follow-ups.
- 10 July 2023
- Published by Brieflands in International Journal of Cardiovascular Practice
- Vol. 7 (2)
Open AccessSurgical Outcomes of Repairing Ebstein Anomaly: A Single-Center Experience
Background: Ebstein anomaly (EA) is a rare congenital disorder of the tricuspid valve (TV), accounting for about one percent of congenital heart defects. Considering highly variable anatomy, diverse corrective surgical methods are currently utilized. Cone reconstruction provides a near anatomic tricuspid restoration method that has triggered enthusiasm for early repair over recent years. Objectives: In the current study, we aimed to evaluate the clinical and echocardiographic features and outcomes of patients who underwent surgical correction of EA in our referral center. Methods: In this study, we reviewed the medical records of 35 patients with EA who underwent cone repair or TV replacement and had accessible echocardiographic data before and at least one year following the corrective surgery. The patients were evaluated for residual tricuspid regurgitation (TR) severity, right ventricular (RV) size, RV fractional area change (FAC), left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), and 2D left ventricular ejection fraction (LVEF) before and after the operation. Results: Mean age of the patients was 29.49 ± 9.13 years, and 54.3% of them were female. Twenty-one (60%) patients underwent cone repair, and 14 were subjected to TV replacement. Seven (20%) patients required reoperation; redo TV repair was conducted in three patients (8.6%); two (5.7%) patients underwent biologic TV replacement; mechanical TV replacement was performed in one patient (2.9%) who had degenerative biologic TVs, and one patient (2.9%) was subjected to redo-operation due to mechanical TV malfunction. Positive changes in the means of RV-FAC and 2D-LVEF were statistically significant in all patients irrespective of the type of surgery (P < 0.001), but changes in the means of RV size (P = 0.38) and LVESD (P = 0.302) were not statistically significant. There was a significant increase in functional RV size in both groups of patients who underwent repair (P = 0.063) or replacement (P = 0.02). Conclusions: The present study revealed satisfactory post-op results for cone TV repair in patients with EA, evidenced by reduced TR severity and improved biventricular functional parameters. Assessing the durability of the outcomes of cone TV repair needs longer-term follow-ups.
- Open Access
- 1 April 2023
- Published by Medknow in Research in Cardiovascular Medicine
- Vol. 12 (2) , 52-55
Safety and Efficacy of Patent Foramen Ovale Device Closure: Evaluation of Outcomes in a Tertiary Referral Center
Aim and Objectives: Recent randomized controlled trials have demonstrated the benefit of patent foramen ovale (PFO) device closure over medical therapy alone for secondary prevention of cryptogenic stroke in carefully selected patients. In the current study, we sought to investigate the outcomes and complications of PFO device closure in our referral tertiary cardiovascular center. Materials and Methods: In this retrospective study, 155 adult patients who underwent PFO device closure between 2006 and 2021 were included. Patient characteristics, recurrent neurologic events, and procedure-related complications were evaluated. Results: The follow-up period was 2.3 ± 1.2 years. The average age of the participants was 41.3 ± 10 years, and 59.4% were male. Six patients (3.9%) suffered recurrent cerebrovascular events in the follow-up. No procedure-related complications were reported in our study population. Two patients (1.3%) with recurrent stroke had developed newly diagnosed atrial fibrillation (AF). Conclusion: PFO device closure is a safe and effective method for the prevention of recurrent ischemic stroke in patients with no other detectable etiology. Patients, particularly those with cardiovascular risk factors, should be meticulously investigated for the asymptomatic episodes of AF as the contributing factor with prolonged Holter monitoring or use of loop recorders.
- 1 April 2023
- Published by Medknow in Research in Cardiovascular Medicine
- Vol. 12 (2) , 52-55
Open AccessSafety and Efficacy of Patent Foramen Ovale Device Closure: Evaluation of Outcomes in a Tertiary Referral Center
Aim and Objectives: Recent randomized controlled trials have demonstrated the benefit of patent foramen ovale (PFO) device closure over medical therapy alone for secondary prevention of cryptogenic stroke in carefully selected patients. In the current study, we sought to investigate the outcomes and complications of PFO device closure in our referral tertiary cardiovascular center. Materials and Methods: In this retrospective study, 155 adult patients who underwent PFO device closure between 2006 and 2021 were included. Patient characteristics, recurrent neurologic events, and procedure-related complications were evaluated. Results: The follow-up period was 2.3 ± 1.2 years. The average age of the participants was 41.3 ± 10 years, and 59.4% were male. Six patients (3.9%) suffered recurrent cerebrovascular events in the follow-up. No procedure-related complications were reported in our study population. Two patients (1.3%) with recurrent stroke had developed newly diagnosed atrial fibrillation (AF). Conclusion: PFO device closure is a safe and effective method for the prevention of recurrent ischemic stroke in patients with no other detectable etiology. Patients, particularly those with cardiovascular risk factors, should be meticulously investigated for the asymptomatic episodes of AF as the contributing factor with prolonged Holter monitoring or use of loop recorders.
- 23 November 2022
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 72 (1) , 44-47
Right ventricular echocardiographic remodeling after pulmonary valve replacement in repaired Tetralogy of Fallot
- 23 November 2022
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 72 (1) , 44-47
Right ventricular echocardiographic remodeling after pulmonary valve replacement in repaired Tetralogy of Fallot
- 7 September 2022
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 30 (9) , 1023-1024
A giant aneurysm of sinus of Valsalva presenting with frequent syncopal attacks
Sinus of Valsalva aneurysm is a rare congenital or acquired aortic root anomaly. The aneurysm has the potential to compress the adjacent structures or rupture to other cardiac chambers with fatal consequences. Patients might be asymptomatic or present with nonspecific cardiac symptoms. Once the diagnosis is made, prompt surgical repair is generally required. Here, we present a young woman with frequent syncope who was found to have a giant sinus of Valsalva aneurysm as the underlying etiology.
- 7 September 2022
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 30 (9) , 1023-1024
A giant aneurysm of sinus of Valsalva presenting with frequent syncopal attacks
Sinus of Valsalva aneurysm is a rare congenital or acquired aortic root anomaly. The aneurysm has the potential to compress the adjacent structures or rupture to other cardiac chambers with fatal consequences. Patients might be asymptomatic or present with nonspecific cardiac symptoms. Once the diagnosis is made, prompt surgical repair is generally required. Here, we present a young woman with frequent syncope who was found to have a giant sinus of Valsalva aneurysm as the underlying etiology.
- 31 May 2022
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 80 (5) , 548-552
Safety and feasibility of simultaneous left and right heart catheterization via single-arm arterial and venous access
Background: Catheterization via the radial artery has become the method of choice for evaluation of the coronary arteries; however in patients requiring simultaneous coronary and right heart catheterization upper extremity access is not commonly used. Aims: In the present study we aimed to assess whether simultaneous left and right heart catheterization via the radial artery and antecubital vein might increase the vascular access site complications. Methods: In this prospective cohort study, 49 patients with congenital and valvular heart disease requiring both left and right heart catheterization were enrolled, and rates of vascular access complications, including radial artery obstruction (RAO), were compared to 49 subjects in the control group who underwent catheterization only via radial artery access. Results: No major vascular complications occurred in the study population. Post-procedural radial artery obstruction was detected in 14 patients (28.5%) in the venous-radial artery group and 7 (14.2%) in the control group (P = 0.09). Age, sex, body mass index, wrist circumference, hemoglobin concentrations, and history of smoking, diabetes mellitus, hypertension, and anticoagulant use did not affect the rate of radial pulse perseverance. However, shorter times of radial compression device removal were significantly related to lower rates of radial artery obstruction in both groups. Conclusion: Right and left heart catheterization via an upper-extremity route in patients with congenital and valvular heart disease is safe and practical with greater patient comfort and no serious vascular complications. A longer duration of radial compression is an important predictor of RAO, regardless of using additional upper-extremity venous access.
- 31 May 2022
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 80 (5) , 548-552
Safety and feasibility of simultaneous left and right heart catheterization via single-arm arterial and venous access
Background: Catheterization via the radial artery has become the method of choice for evaluation of the coronary arteries; however in patients requiring simultaneous coronary and right heart catheterization upper extremity access is not commonly used. Aims: In the present study we aimed to assess whether simultaneous left and right heart catheterization via the radial artery and antecubital vein might increase the vascular access site complications. Methods: In this prospective cohort study, 49 patients with congenital and valvular heart disease requiring both left and right heart catheterization were enrolled, and rates of vascular access complications, including radial artery obstruction (RAO), were compared to 49 subjects in the control group who underwent catheterization only via radial artery access. Results: No major vascular complications occurred in the study population. Post-procedural radial artery obstruction was detected in 14 patients (28.5%) in the venous-radial artery group and 7 (14.2%) in the control group (P = 0.09). Age, sex, body mass index, wrist circumference, hemoglobin concentrations, and history of smoking, diabetes mellitus, hypertension, and anticoagulant use did not affect the rate of radial pulse perseverance. However, shorter times of radial compression device removal were significantly related to lower rates of radial artery obstruction in both groups. Conclusion: Right and left heart catheterization via an upper-extremity route in patients with congenital and valvular heart disease is safe and practical with greater patient comfort and no serious vascular complications. A longer duration of radial compression is an important predictor of RAO, regardless of using additional upper-extremity venous access.
- Open Access
- 28 April 2022
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 74 (1) , 1-4
Multiple congenital visceral abnormalities as a rare cause of pulmonary arterial hypertension
Background: Pulmonary arterial hypertension (PAH) is a rare, progressive disorder. PAH is caused by a wide spectrum of pathologies but the cause remains undetermined on many occasions and patients are classified in the idiopathic group. Case presentation: Here we report a young woman with rare congenital visceral abnormalities presenting with severe pulmonary hypertension. Conclusions: Pulmonary hypertension is a complex disorder. Search for uncommon conditions that lead to pulmonary hypertension is necessary to determine the best management options.
- 28 April 2022
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 74 (1) , 1-4
Open AccessMultiple congenital visceral abnormalities as a rare cause of pulmonary arterial hypertension
Background: Pulmonary arterial hypertension (PAH) is a rare, progressive disorder. PAH is caused by a wide spectrum of pathologies but the cause remains undetermined on many occasions and patients are classified in the idiopathic group. Case presentation: Here we report a young woman with rare congenital visceral abnormalities presenting with severe pulmonary hypertension. Conclusions: Pulmonary hypertension is a complex disorder. Search for uncommon conditions that lead to pulmonary hypertension is necessary to determine the best management options.
- 15 January 2022
- Published by Wiley in Echocardiography
- Vol. 39 (2) , 387-389
Incidental detection of ruptured sinus of Valsalva aneurysm and coronary abnormality in a patient with penetrating chest trauma
Aortic sinus of Valsalva aneurysm is a rare congenital or acquired anomaly with a potential for rupture into adjacent cardiac chambers. Ruptured aneurysm of the sinus of Valsalva leads to volume overload of the receiving chamber and should be repaired as soon as the diagnosis is made. Here, we present a young patient with history of chest trauma leading to discovery of an asymptomatic ruptured sinus of Valsalva aneurysm.
- 15 January 2022
- Published by Wiley in Echocardiography
- Vol. 39 (2) , 387-389
Incidental detection of ruptured sinus of Valsalva aneurysm and coronary abnormality in a patient with penetrating chest trauma
Aortic sinus of Valsalva aneurysm is a rare congenital or acquired anomaly with a potential for rupture into adjacent cardiac chambers. Ruptured aneurysm of the sinus of Valsalva leads to volume overload of the receiving chamber and should be repaired as soon as the diagnosis is made. Here, we present a young patient with history of chest trauma leading to discovery of an asymptomatic ruptured sinus of Valsalva aneurysm.